Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Kristi Henjum(Oslo University Hospital), Lars Nilsson(University of South Florida), Vibeke Årskog(Oslo University Hospital), Tormod Fladby(University of Oslo), Lennart Minthon(Lund University), Oskar Hansson(Eli Lilly (United States)), Ina S. Almdahl(Oslo University Hospital)
Cited by 147
Related Papers
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k